Literature DB >> 22668023

The relationship of multifocality and tumor burden with various tumor characteristics and survival in early breast cancer.

G Kelemen1, V Farkas, J Debrah, K Ormandi, A Voros, L Kaizer, Z Varga, G Lazar, Z Kahan.   

Abstract

The presence of multifocality and the aggregate tumor size were retrospectively analysed in a database of 1071 operated breast cancers. Around a quarter of all these cancers involved multiple foci, while a tenth of the total demonstrated more than one invasive focus. Although the multifocal cancers were smaller and more often screen-detected than the unifocal cancers, their aggregate tumor size was larger, and they more frequently displayed casting-type calcifications in the mammogram and HER2 positivity. Lobular histology favoured larger tumor burden. The invasive multifocal cancers were more commonly lymph node-positive than the other tumors. In a subgroup of 584 patients with a median follow-up time of 5 years, the larger size of the invasive tumor, the presence of LVI or lymph node involvement, HER2 positivity and triple negativity were associated with a poorer RFS and OS, while the outcome of screen-detected tumors was superior to that of non-screen-detected or interval cancers. A large tumor size, lymph node positivity and HER2 positive or triple negative phenotypes were independent determinants of a poorer survival rate.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22668023     DOI: 10.4149/neo_2012_073

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  2 in total

1.  Synchronous Multiple Breast Cancers-Do We Need to Reshape Staging?

Authors:  Minodora Onisâi; Adrian Dumitru; Iuliana Iordan; Cătălin Aliuș; Oana Teodor; Adrian Alexandru; Daniela Gheorghiță; Iulian Antoniac; Adriana Nica; Alexandra-Ana Mihăilescu; Sebastian Grădinaru
Journal:  Medicina (Kaunas)       Date:  2020-05-11       Impact factor: 2.430

2.  Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study.

Authors:  L Holmberg; Y N S Wong; L Tabár; A Ringberg; P Karlsson; L-G Arnesson; K Sandelin; H Anderson; H Garmo; S Emdin
Journal:  Br J Cancer       Date:  2013-01-31       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.